Hong Graham Number from 2010 to 2026
| HKPD Stock | 0.83 0 0.36% |
Graham Number | First Reported 2010-12-31 | Previous Quarter 1.38 | Current Value 0.74 | Quarterly Volatility 0.45296236 |
Check Hong Kong financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hong Kong's main balance sheet or income statement drivers, such as Tax Provision of 103.4 K, Interest Income of 2.1 K or Depreciation And Amortization of 995 K, as well as many indicators such as Price To Sales Ratio of 0.52, Dividend Yield of 0.0 or PTB Ratio of 2.13. Hong financial statements analysis is a perfect complement when working with Hong Kong Valuation or Volatility modules.
Hong | Graham Number | Build AI portfolio with Hong Stock |
Analyzing Hong Kong's Graham Number over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Graham Number has evolved provides context for assessing Hong Kong's current valuation and future prospects.
Latest Hong Kong's Graham Number Growth Pattern
Below is the plot of the Graham Number of Hong Kong Pharma over the last few years. It is Hong Kong's Graham Number historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hong Kong's overall financial position and show how it may be relating to other accounts over time.
| Graham Number | 10 Years Trend |
|
Graham Number |
| Timeline |
Hong Graham Number Regression Statistics
| Arithmetic Mean | 0.56 | |
| Geometric Mean | 0.45 | |
| Coefficient Of Variation | 81.33 | |
| Mean Deviation | 0.35 | |
| Median | 0.33 | |
| Standard Deviation | 0.45 | |
| Sample Variance | 0.21 | |
| Range | 1.202 | |
| R-Value | 0.65 | |
| Mean Square Error | 0.13 | |
| R-Squared | 0.42 | |
| Significance | 0 | |
| Slope | 0.06 | |
| Total Sum of Squares | 3.28 |
Hong Graham Number History
About Hong Kong Financial Statements
Hong Kong stakeholders use historical fundamental indicators, such as Hong Kong's Graham Number, to determine how well the company is positioned to perform in the future. Although Hong Kong investors may analyze each financial statement separately, they are all interrelated. For example, changes in Hong Kong's assets and liabilities are reflected in the revenues and expenses on Hong Kong's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Hong Kong Pharma. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Graham Number | 1.38 | 0.74 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Hong Kong Pharma is a strong investment it is important to analyze Hong Kong's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Hong Kong's future performance. For an informed investment choice regarding Hong Stock, refer to the following important reports:Check out the analysis of Hong Kong Correlation against competitors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Will Air Freight & Logistics sector continue expanding? Could Hong diversify its offerings? Factors like these will boost the valuation of Hong Kong. Market participants price Hong higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Hong Kong data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.302 | Revenue Per Share | Quarterly Revenue Growth (0.05) | Return On Assets | Return On Equity |
The market value of Hong Kong Pharma is measured differently than its book value, which is the value of Hong that is recorded on the company's balance sheet. Investors also form their own opinion of Hong Kong's value that differs from its market value or its book value, called intrinsic value, which is Hong Kong's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Hong Kong's market value can be influenced by many factors that don't directly affect Hong Kong's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hong Kong's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hong Kong is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Hong Kong's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.